Company
United StatesPublic company, NASDAQ: HWKNHawkins, Inc. (NASDAQ: HWKN), Minneapolis, MN – FDA Inspections
Inspection records and compliance data for Hawkins, Inc. in Minneapolis, Minnesota. 4 FDA inspections on record, last inspected October 18, 2019. Publicly traded as NASDAQ: HWKN.
Company Profile
This profile covers Hawkins, Inc. based in Minneapolis, Minnesota, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 1
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected April 3, 2009. Last inspected October 18, 2019.
Most cited issue areas
- Components withheld from use pending release1 inspection
- Procedures to be written and followed1 inspection
- Reports of Analysis (Components)1 inspection
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| October 18, 2019 | NAI | Foods & Cosmetics · Foodborne Biological Hazards | 1107834 |
| February 13, 2015 | NAI | Foods & Cosmetics · Foodborne Biological Hazards | 914903 |
| August 17, 2010 | NAI | Human Drugs · Drug Quality Assurance | 676139 |
| April 3, 2009 | VAI | Human Drugs · Drug Quality Assurance | 572638 |
FDA documents
EIRs (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Hawkins, Inc.
Stock ticker
HWKN
Exchange
NASDAQ
Share price
$150.37
Market cap
$3.1B
Price as of
November 13, 2026
FEI Number
3000719824
Address
3100 E Hennepin Ave, Minneapolis, Minnesota 55413, United States
Country
United States
ID: 84b7c90f-0977-451a-8550-c7ef9e833730